Robert Brenner serves as the Chief Medical Officer at Vera Therapeutics, Inc. since January 2024 and is a Co-Founder of Cru Bio, which focuses on innovative therapies for kidney and related diseases, starting in August 2022. Previously, Robert held positions such as Executive in Residence at 6 Dimensions Capital from February 2020 to February 2022, Executive Vice President of Research and Development at Codiak BioSciences from September 2018 to March 2019, and Executive Vice President and Chief Medical Officer at Orionis Biosciences from December 2015 to September 2018. Robert's educational background includes a Fellowship in Nephrology from Stanford University School of Medicine and a Residency in Internal Medicine at Brigham and Women's Hospital.
This person is not in any teams
This person is not in any offices